Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3323 ARTÍCULOS , VIENDO DEL 901 AL 915

Neurobiology of Huntington's Disease: Applications to Drug Discovery

Lo DC, Hughes RE, editors.

Boca Raton (FL): CRC Press/Taylor & Francis; 2011.

Target Validation for Huntington’s Disease

Kwak SP, Wang JKT, Howland DS.

In: Lo DC, Hughes RE, editors. Neurobiology of Huntington's Disease: Applications to Drug Discovery. Boca Raton (FL): CRC Press/Taylor & Francis; 2011. Chapter 4.

Recombinant Intrabodies as Molecular Tools and Potential Therapeutics for Huntington’s Disease

Ali K, Southwell AL, Bugg CW, Ko JC, Patterson PH.

In: Lo DC, Hughes RE, editors. Neurobiology of Huntington's Disease: Applications to Drug Discovery. Boca Raton (FL): CRC Press/Taylor & Francis; 2011. Chapter 10.

Huntington’s Disease: Clinical Features and Routes to Therapy

Paulson HL, Albin RL.

In: Lo DC, Hughes RE, editors. Neurobiology of Huntington's Disease: Applications to Drug Discovery. Boca Raton (FL): CRC Press/Taylor & Francis; 2011. Chapter 1.

Pharmaceutical Development for Huntington’s Disease

Morse RJ, Leeds JM, Macdonald D, Park L, Toledo-Sherman L, Pacifici R.

In: Lo DC, Hughes RE, editors. Neurobiology of Huntington's Disease: Applications to Drug Discovery. Boca Raton (FL): CRC Press/Taylor & Francis; 2011. Chapter 8.

Permanent haemichorea associated with transient hyperglycemia

Slabu H, Savedia-Cayabyab S, Senior P, Arnason T.

BMJ Case Rep. 2011 Oct 4;2011:bcr0820114641. doi: 10.1136/bcr.08.2011.4641.

Analyzing the aggregation of polyglutamine-expansion proteins and its modulation by molecular chaperones

Kubota H, Kitamura A, Nagata K.

Methods. 2011 Mar;53(3):267-74. doi: 10.1016/j.ymeth.2010.12.035. Epub 2010 Dec 30.

It wasn't Witchcraft--It was Huntington Disease!

Penaranda E, Garcia A, Montgomery L.

J Am Board Fam Med. 2011 Jan-Feb;24(1):115-6. doi: 10.3122/jabfm.2011.01.100145.

Role of inositol 1,4,5-trisphosphate receptors in pathogenesis of Huntington's disease and spinocerebellar ataxias

Bezprozvanny I.

Neurochem Res. 2011 Jul;36(7):1186-97. doi: 10.1007/s11064-010-0393-y. Epub 2011 Jan 6.

Impaired ideomotor limb apraxia in cortical and subcortical dementia: a comparison of Alzheimer's and Huntington's disease

Holl AK, Ille R, Wilkinson L, Otti DV, Hödl E, Herranhof B, Reisinger KM, Müller N, Painold A, Holl EM, Letmaier M, Bonelli RM.

Neurodegener Dis. 2011;8(4):208-15. doi: 10.1159/000322230. Epub 2011 Jan 5.

Reversible striatal hypermetabolism in a case of rare adult-onset Sydenham chorea on two sequential 18F-FDG PET studies

Paghera B, Caobelli F, Giubbini R, Premi E, Padovani A.

J Neuroradiol. 2011 Dec;38(5):325-6. doi: 10.1016/j.neurad.2010.10.002. Epub 2011 Jan 6.

Multivesicular bodies in neurons: distribution, protein content, and trafficking functions

Von Bartheld CS, Altick AL.

Prog Neurobiol. 2011 Mar;93(3):313-40. doi: 10.1016/j.pneurobio.2011.01.003. Epub 2011 Jan 7.

Primary diffuse large B-cell lymphoma of the skull mimicking osteomyelitis

Senthilvel E, Subbiah S, Jain V, Seidman M.

Ear Nose Throat J. 2011 Jan;90(1):E22-5. doi: 10.1177/014556131109000117.

Novel high-throughput assay to assess cellular manganese levels in a striatal cell line model of Huntington's disease confirms a deficit in manganese accumulation

Kwakye GF, Li D, Bowman AB.

Neurotoxicology. 2011 Oct;32(5):630-9. doi: 10.1016/j.neuro.2011.01.002. Epub 2011 Jan 14.

Evidence-based guideline update: Plasmapheresis in neurologic disorders [RETIRED]: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

Cortese I, Chaudhry V, So YT, Cantor F, Cornblath DR, Rae-Grant A.

Neurology. 2011 Jan 18;76(3):294-300. doi: 10.1212/WNL.0b013e318207b1f6.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias